Dezhan Healthcare Co Ltd
000813
Company Profile
Business description
Dezhan Healthcare Co Ltd's main business is drug research and development, production, and sales. The company's wholly-owned subsidiary Jialin Pharmaceuticals mainly engages in the research and development, production, and sale of cardiovascular drugs, the drugs being produced and sold including Ale (10mg), Alle (20mg), hydrochloric acid quercetine capsules, Van Le tablets type 1, Van Le tablets.
Contact
No. 235 Yin Chuan Road
Xinjiang
Urumqi830054
CHNT: +86 9914336078
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,002
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,913.90 | 352.20 | 4.66% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,913.25 | 233.77 | 3.04% |
| HKSE | 20,681.78 | 417.29 | 2.06% |
| NASDAQ | 16,421.05 | 703.92 | -4.11% |
| Nikkei 225 | 34,609.00 | 2,894.97 | 9.13% |
| NZX 50 Index | 12,027.66 | 173.77 | -1.42% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,709.60 | 334.60 | 4.54% |
| SSE Composite Index | 3,223.64 | 36.83 | 1.16% |